MAVENAGE · MAV-CSS-2024-0385

Observational research on the use of cladribine tablets in real-world clinical practice to evaluate their safety and effectiveness in adult patients with relapsing multiple sclerosis, comparing groups by age.

A prospective observational study to evaluate the effectiveness and safety profile of cladribine tablets in a real-world cohort of relapsing multiple sclerosis patients older and younger than 50 years

Sponsor: MERCK

Phase: IV

Status: Follow-up

View clinical trials catalogue